Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nematode
EAK
-7 (enhancer-of-
akt
-1-7) regulates dauer formation and controls life span; however, the function of the human ortholog mammalian
EAK
-7 (mEAK-7) is unknown. We report that mEAK-7 activates an alternative mechanistic/
mammalian target of rapamycin
(
mTOR
) signaling pathway in human cells, in which mEAK-7 interacts with
mTOR
at the lysosome to facilitate S6K2 activation and 4E-BP1 repression. Despite interacting with
mTOR
and mammalian lethal with SEC13 protein 8 (mLST8), mEAK-7 does not interact with other
mTOR
complex 1 (mTORC1) or
mTOR
complex 2 (mTORC2) components; however, it is essential for
mTOR
signaling at the lysosome. This phenomenon is distinguished by S6 and 4E-BP1 activity in response to nutrient stimulation. Conventional S6K1 phosphorylation is uncoupled from S6 phosphorylation in response to mEAK-7 knockdown. mEAK-7 recruits
mTOR
to the lysosome, a crucial compartment for
mTOR
activation. Loss of mEAK-7 results in a marked decrease in lysosomal localization of
mTOR
, whereas overexpression of mEAK-7 results in enhanced lysosomal localization of
mTOR
. Deletion of the carboxyl terminus of mEAK-7 significantly decreases
mTOR
interaction. mEAK-7 knockdown decreases cell proliferation and migration, whereas overexpression of mEAK-7 enhances these cellular effects. Constitutively activated S6K rescues
mTOR
signaling in mEAK-7-knocked down cells. Thus, mEAK-7 activates an alternative
mTOR
signaling pathway through S6K2 and 4E-BP1 to regulate cell proliferation and migration.
...
PMID:Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration. 2975 Jan 93